The pharmacology of neurokinin receptors in addiction: prospects for therapy

References

• Trends and Statistics Available from http://www.drugabuse.gov/related-topics/trends-statistics#costsAccessed July 28, 2015
   Google Scholar
• VolkowNWhat is the Federal Government doing to Combat the Opioid Abuse Epidemic?Bethesda, MDNIDA: NIH2015
   Google Scholar
• V EulerUSGaddumJHAn unidentified depressor substance in certain tissue extractsJ Physiol1931721748716994201
   PubMedGoogle Scholar
• GaddumJHSchildHDepressor substances in extracts of intestineJ Physiol193483111416994608
   PubMedGoogle Scholar
• PernowBDistribution of substance P in the central and peripheral nervous systemNature1953171435674613054699
   PubMed Web of Science ®Google Scholar
• YakshTLJessellTMGamseRMudgeAWLeemanSEIntrathecal morphine inhibits substance P release from mammalian spinal cord in vivoNature198028657691551576157098
   PubMed Web of Science ®Google Scholar
• ChangMMLeemanSEIsolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance PJ Biol Chem197024518478447905456150
   PubMed Web of Science ®Google Scholar
• MrozEDBrownsteinMJLeemanSEEvidence for substance P in the habenulo-interpeduncular tractBrain Res19761133597599953755
   PubMed Web of Science ®Google Scholar
• KanazawaIEmsonPCCuelloACEvidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brainBrain Res19771192447453830395
   PubMed Web of Science ®Google Scholar
• NapierTCMitrovicIChurchillLKlitenickMALuXYKalivasPWSubstance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance PNeuroscience199569159708637633
   PubMed Web of Science ®Google Scholar
• CuelloACJessellTMKanazawaIIversenLLSubstance P: localization in synaptic vesicles in rat central nervous systemJ Neurochem1977294747751591950
   PubMed Web of Science ®Google Scholar
• KellyPHIversenSDSelective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in ratsEur J Pharmacol197640145561033072
   PubMed Web of Science ®Google Scholar
• SpyrakiCFibigerHCPhillipsAGAttenuation of heroin reward in rats by disruption of the mesolimbic dopamine systemPsychophamacology1983792–3278283
   Web of Science ®Google Scholar
• BaikJHDopamine signaling in reward-related behaviorsFront Neural Circuits2013715224130517
   PubMed Web of Science ®Google Scholar
• StinusLKelleyAEIversenSDIncreased spontaneous activity following substance P infusion into A10 dopaminergic areaNature19782765688616618214711
   PubMed Web of Science ®Google Scholar
• ErspamerVAnastasiAPolypeptides active on plain muscle in the amphibian skinPaper presented at: Proceedings of the International Symposium: Hypotensive PeptidesOctober 25–29, 19651966Florence, Italy
   Google Scholar
• KimuraSOkadaMSugitaYKanazawaIMunekataENovel neuropeptides, neurokinin-alpha and neurokinin-beta isolated from porcine spinal-cordP Jpn Acad B Phys1983594101104
   Web of Science ®Google Scholar
• BuckSHBurcherEShultsCWLovenbergWO’DonohueTLNovel pharmacology of substance K-binding sites: a third type of tachykinin receptorScience198422646779879896095447
   PubMed Web of Science ®Google Scholar
• HenryJLSubstance P and neurokininsPaper presented at: Proceedings of “Substance P and Neurokinins-Montreal ’86.” A Satellite Symposium of the XXX International Congress of The International Union of Physiological Sciences1986Montreal, Canada
   Google Scholar
• RegoliDDrapeauGDionSD’Orleans-JustePPharmacological receptors for substance P and neurokininsLife Sci19874021091172432376
   PubMed Web of Science ®Google Scholar
• MantyhPWPinnockRDDownesCPGoedertMHuntSPCorrelation between inositol phospholipid hydrolysis and substance P receptors in rat CNSNature198430959717957976204206
   PubMed Web of Science ®Google Scholar
• MantyhPWAllenCJGhilardiJRRapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivoProc Natl Acad Sci U S A1995927262226267535928
   PubMed Web of Science ®Google Scholar
• SteinhoffMSvon MentzerBGeppettiPPothoulakisCBunnettNWTachykinins and their receptors: contributions to physiological control and the mechanisms of diseasePhysiol Rev201494126530124382888
   PubMed Web of Science ®Google Scholar
• LuBSuYDasSPeptide neurotransmitters activate a cation channel complex of NALCN and UNC-80Nature2009457723074174419092807
   PubMed Web of Science ®Google Scholar
• Koike-TaniMCollinsJMKawanoTSignal transduction pathway for the substance P-induced inhibition of rat Kir3 (GIRK) channelJ Physiol2005564Pt 248950015731196
   PubMed Web of Science ®Google Scholar
• IversenLIversen LeslieSquireLRThe History of Neuroscience in Autobiography6OxfordOxford University Press2009190225
   Google Scholar
• SniderRMConstantineJWLoweJAIIIA potent nonpeptide antagonist of the substance P (NK1) receptorScience199125149924354371703323
   PubMed Web of Science ®Google Scholar
• KramerMSCutlerNFeighnerJDistinct mechanism for antidepressant activity by blockade of central substance P receptorsScience19982815383164016459733503
   PubMed Web of Science ®Google Scholar
• HillRNK1 (substance P) receptor antagonists – why are they not analgesic in humans?Trends Pharmacol Sci200021724424610871891
   PubMed Web of Science ®Google Scholar
• LjungdahlAHokfeltTNilssonGDistribution of substance P-like immunoreactivity in the central nervous system of the rat – I. Cell bodies and nerve terminalsNeuroscience1978310861943366451
   PubMed Web of Science ®Google Scholar
• BowmanSLSoohooALShiwarskiDJSchulzSPradhanAAPuthenveeduMACell-Autonomous Regulation of Mu-Opioid Receptor Recycling by Substance PCell Rep201510111925193625801029
   PubMed Web of Science ®Google Scholar
• SantarelliLGobbiGBlierPHenRBehavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1)J Clin Psychiatry200263Suppl 11111712562138
   PubMed Web of Science ®Google Scholar
• MantyhPWNeurobiology of substance P and the NK1 receptorJ Clin Psychiatry200263Suppl 1161012562137
   PubMed Web of Science ®Google Scholar
• WiseRAKoobGFThe development and maintenance of drug addictionNeuropsychopharmacology201439225426224121188
   PubMed Web of Science ®Google Scholar
• ElliottPJMasonGSStephens-SmithMHaganRMBehavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonistsNeuropeptides19911921191261719444
   PubMed Web of Science ®Google Scholar
• DamTVEscherEQuirionRVisualization of neurokinin-3 receptor sites in rat brain using the highly selective ligand [3H]senktideBrain Res199050611751791689199
   PubMed Web of Science ®Google Scholar
• MantyhPWGatesTMantyhCRMaggioJEAutoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissuesJ Neurosci1989912582792536418
   PubMed Web of Science ®Google Scholar
• SeabrookGRBoweryBJHillRGPharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slicesEur J Pharmacol19952731–21131197537676
   PubMed Web of Science ®Google Scholar
• MinabeYEmoriKToorAStutzmannGEAshbyCRJrThe effect of the acute and chronic administration of CP 96,345, a selective neu-rokinin1 receptor antagonist, on midbrain dopamine neurons in the rat: a single unit, extracellular recording studySynapse199622135458822476
   PubMed Web of Science ®Google Scholar
• KorotkovaTMBrownRESergeevaOAPonomarenkoAAHaasHLEffects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the ratEur J Neurosci200623102677268516817870
   PubMed Web of Science ®Google Scholar
• Sanchez-CatalanMJKauflingJGeorgesFVeinantePBarrotMThe antero-posterior heterogeneity of the ventral tegmental areaNeuroscience2014282C19821625241061
   PubMed Web of Science ®Google Scholar
• LessardAPickelVMSubcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental areaNeuroscience200513541309132316165296
   PubMed Web of Science ®Google Scholar
• LessardAGradyEFBunnettNWPickelVMPredominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental areaNeuroscience200714441393140817197098
   PubMed Web of Science ®Google Scholar
• LessardASavardMGobeilFJrPierceJPPickelVMThe neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental areaSynapse200963648450119224600
   PubMed Web of Science ®Google Scholar
• HetherSMisonoKLessardAThe neurokinin-3 receptor (NK3R) antagonist SB222200 prevents the apomorphine-evoked surface but not nuclear NK3R redistribution in dopaminergic neurons of the rat ventral tegmental areaNeuroscience2013247122423673279
   PubMed Web of Science ®Google Scholar
• SladekCDStevensWLevinsonSRSongZJensenDDFlynnFWCharacterization of nuclear neurokinin 3 receptor expression in rat brainNeuroscience2011196354821939739
   PubMed Web of Science ®Google Scholar
• MinabeYAshbyCRJrEffect of the acute and chronic administration of the selective neurokinin2 receptor antagonist SR 48968 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell studySynapse19972521962049021900
   PubMed Web of Science ®Google Scholar
• SchmidlinFDeryOBunnettNWGradyEFHeterologous regulation of trafficking and signaling of G protein-coupled receptors: beta-arrestin-dependent interactions between neurokinin receptorsProc Natl Acad Sci U S A20029953324332911880656
   PubMed Web of Science ®Google Scholar
• StaubliUHustonJPCentral action of substance P: possible role in rewardBehav Neural Biol19854311001082581538
   PubMedGoogle Scholar
• PlacenzaFMFletcherPJRotzingerSVaccarinoFJInfusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in ratsPsychopharmacology20041771–211112015167979
   PubMed Web of Science ®Google Scholar
• MogensonGJWuMJonesDLLocomotor activity elicited by injections of picrotoxin into the ventral tegmental area is attenuated by injections of GABA into the globus pallidusBrain Res198019125695717378773
   PubMed Web of Science ®Google Scholar
• AmbroggiFIshikawaAFieldsHLNicolaSMBasolateral amygdala neurons facilitate reward-seeking behavior by exciting nucleus accumbens neuronsNeuron200859464866118760700
   PubMed Web of Science ®Google Scholar
• SchildeinSAgmoAHustonJPSchwartingRKIntraaccumbens injections of substance P, morphine and amphetamine: effects on conditioned place preference and behavioral activityBrain Res19987901–21851949593886
   PubMed Web of Science ®Google Scholar
• ElliottPJNemeroffCBKiltsCDEvidence for a tonic facilitatory influence of substance P on dopamine release in the nucleus accumbensBrain Res198638523793822430671
   PubMed Web of Science ®Google Scholar
• LoonamTMNoaillesPAYuJZhuJPAnguloJASubstance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatumLife Sci200373672773912801594
   PubMed Web of Science ®Google Scholar
• BeachTGTagoHMcGeerEGLight microscopic evidence for a substance P-containing innervation of the human nucleus basalis of MeynertBrain Res19874081–22512572439166
   PubMed Web of Science ®Google Scholar
• HasenohrlRUGerhardtPHustonJPPositively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequenceExp Neurol199211522822911370940
   PubMed Web of Science ®Google Scholar
• NikolausSHustonJPHasenohrlRUReinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptorEur J Pharmacol19993702939910323256
   PubMed Web of Science ®Google Scholar
• BoixFSandorPNogueiraPJHustonJPSchwartingRKRelationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis regionNeuroscience1995644104510557538637
   PubMed Web of Science ®Google Scholar
• CiccocioppoRPanockaIPolidoriCDe CaroGRegoliDMassiMStimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in ratsPeptides1997189134913559392836
   PubMed Web of Science ®Google Scholar
• CiccocioppoRPanockaIPolidoriCFroldiRAngelettiSMassiMMechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktidePharmacol Biochem Behav19986144594649802842
   PubMed Web of Science ®Google Scholar
• FurutaTMoriTLeeTKanekoTThird group of neostriatofugal neurons: neurokinin B-producing neurons that send axons predominantly to the substantia innominataJ Comp Neurol2000426227929610982469
   PubMed Web of Science ®Google Scholar
• ZhouLFurutaTKanekoTNeurokinin B-producing projection neurons in the lateral stripe of the striatum and cell clusters of the accumbens nucleus in the ratJ Comp Neurol2004480214316115514933
   PubMed Web of Science ®Google Scholar
• VelasquezKMMolfeseDLSalasRThe role of the habenula in drug addictionFront Hum Neurosci2014817424734015
   PubMed Web of Science ®Google Scholar
• BurgunderJMYoungWSIIINeurokinin B and substance P genes are co-expressed in a subset of neurons in the rat habenulaNeuropeptides19891331651692469031
   PubMed Web of Science ®Google Scholar
• Antolin-FontesBAblesJLGorlichAIbanez-TallonIThe habenulo-interpeduncular pathway in nicotine aversion and withdrawalNeuropharmacology201596Pt B21322225476971
   PubMed Web of Science ®Google Scholar
• GlickSDRamirezRLLiviJMMaisonneuveIM18-Methoxycoonaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in ratsEur J Pharmacol20065371–3949816626688
   PubMed Web of Science ®Google Scholar
• DaoDQPerezEETengYDaniJADe BiasiMNicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signalingJ Neurosci201434124273428424647947
   PubMed Web of Science ®Google Scholar
• NaganoMSaitowFHanedaEKonishiSHayashiMSuzukiHDistribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkeyBr J Pharmacol2006147331632316331282
   PubMed Web of Science ®Google Scholar
• KertesELaszloKBertaBLenardLEffects of substance P microinjections into the globus pallidus and central nucleus of amygdala on passive avoidance learning in ratsBehav Brain Res2009198239740319071162
   PubMed Web of Science ®Google Scholar
• KertesELaszloKBertaBLenardLPositive reinforcing effects of substance P in the rat central nucleus of amygdalaBehav Brain Res2009205130731019555724
   PubMed Web of Science ®Google Scholar
• MurtraPSheasbyAMHuntSPDe FelipeCRewarding effects of opiates are absent in mice lacking the receptor for substance PNature2000405678318018310821273
   PubMed Web of Science ®Google Scholar
• MurtraPSheasbyAHuntSPDe FelipeCLoss of Rewarding Effects of Morphine and Amphetamine, But Not Cocaine, in Mice with Disruption of the Substance P Receptor (NK1) GeneNew Orleans, LASociety for Neuroscience2000
   Google Scholar
• RipleyTLack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptorsNeuropharmacology20024381258126812527475
   PubMed Web of Science ®Google Scholar
• GaddCAMurtraPDe FelipeCHuntSPNeurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouseJ Neurosc2003232382718280
   Web of Science ®Google Scholar
• PlacenzaFMFletcherPJVaccarinoFJErbSEffects of central neurokinin-1 receptor antagonism on cocaine- and opiate-induced locomotor activity and self-administration behaviour in ratsPharmacol Biochem Behav20068419410116757018
   PubMed Web of Science ®Google Scholar
• PlacenzaFMVaccarinoFJFletcherPJErbSActivation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behaviorNeurosci Lett20053901424716125318
   PubMed Web of Science ®Google Scholar
• YangARYiHSMamczarzJJuneHLJrHwangBHJuneHLSrDeficits in substance P mRNA levels in the CeA are inversely associated with alcohol-motivated respondingSynapse2009631197298119593822
   PubMed Web of Science ®Google Scholar
• LumengLHawkinsTDLiTKNew strains of rats with alcohol preference and nonpreferenceRonaldGThurmanJRWDrottHenryChanceBrittonAlcohol and Aldehyde Metabolizing Systems: Intermediary Metabolism and Neurochemistry3New YorkAcademic Press Inc1977537544
   Google Scholar
• HigleyAEKoobGFMasonBJTreatment of alcohol dependence with drug antagonists of the stress responseAlcohol Res201234451652123584117
   PubMed Web of Science ®Google Scholar
• SinhaRHow does stress lead to risk of alcohol relapse?Alcohol Res201234443244023584109
   PubMed Web of Science ®Google Scholar
• EbnerKRupniakNMSariaASingewaldNSubstance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in ratsProc Natl Acad Sci U S A2004101124280428515024126
   PubMed Web of Science ®Google Scholar
• SchankJRPickensCLRoweKEStress-induced reinstatement of alcohol-seeking in rats is selectively suppressed by the neurokinin 1 (NK1) antagonist L822429Psychopharmacology2011218111111921340476
   PubMed Web of Science ®Google Scholar
• ThorsellASchankJRSingleyEHuntSPHeiligMNeurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in micePsychopharmacology2010209110311120112009
   PubMed Web of Science ®Google Scholar
• BaekMNJungKHHalderDArtificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in miceNeurosci Lett2010475312412820347940
   PubMed Web of Science ®Google Scholar
• SteenslandPSimmsJANielsenCKHolgateJBito-OnonJJBartlettSEThe neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanolPLoS One201059e1252720824145
   PubMed Web of Science ®Google Scholar
• JensenCJGerardNPSchwartzTWGetherUThe species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptorsMol Pharmacol19944522942997509441
   PubMed Web of Science ®Google Scholar
• HrabovszkyEBorsayBARaczKSubstance P immunoreactivity exhibits frequent colocalization with kisspeptin and neurokinin B in the human infundibular regionPloS One201388e7236923977290
   PubMed Web of Science ®Google Scholar
• DeaconCFAgostonDVNauRConlonJMConversion of neuropeptide K to neurokinin A and vesicular colocalization of neurokinin A and substance P in neurons of the guinea pig small intestineJ Neurochem19874811411462432172
   PubMed Web of Science ®Google Scholar
• NaganoMOishiTSuzukiHDistribution and pharmacological characterization of primate NK-2 tachykinin receptor in the central nervous system of the rhesus monkeyNeurosci Lett20115031232621855604
   PubMed Web of Science ®Google Scholar
• SteinbergRAlonsoRGriebelGSelective blockade of neurokinin-2 receptors produces antidepressant-like effects associated with reduced corticotropin-releasing factor functionJ Pharmacology Exp Ther20012992449458
   Web of Science ®Google Scholar
• LeggioLCardoneSFerrulliATurning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependenceCurr Pharm Des201016192159211820482506
   PubMed Web of Science ®Google Scholar
• HermanJPGuillonneauDDantzerRScattonBSemerdjian-RouquierLLe MoalMDifferential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the ratLife Sci19823025220722146180276
   PubMed Web of Science ®Google Scholar
• GoldsteinRZVolkowNDDrug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortexAm J Psychiatry2002159101642165212359667
   PubMed Web of Science ®Google Scholar
• HutsonPHPatelSJayMTBartonCLStress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonistEur J Pharmacol20044841576414729382
   PubMed Web of Science ®Google Scholar
• MorleyJEYamadaTWalshJHMorphine addiction and withdrawal alters brain peptide concentrationsLife Sci19802626223922446157071
   PubMed Web of Science ®Google Scholar
• PfriegerFWBarresBASynaptic efficacy enhanced by glial cells in vitroScience19972775332168416879287225
   PubMed Web of Science ®Google Scholar
• KovacsKJMicroglia and drug-induced plasticity in reward-related neuronal circuitsFront Mol Neurosci201257422707932
   PubMed Web of Science ®Google Scholar
• CrewsFTZouJQinLInduction of innate immune genes in brain create the neurobiology of addictionBrain Behav Immun201125Suppl 1S4S1221402143
   PubMed Web of Science ®Google Scholar
• GuoCJDouglasSDGaoZInterleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytesGlia200448325926615390113
   PubMed Web of Science ®Google Scholar
• RasleyABostKLOlsonJKMillerSDMarriottIExpression of functional NK-1 receptors in murine microgliaGlia200237325826711857684
   PubMed Web of Science ®Google Scholar
• YangJYuJJiaXInhibition of nuclear factor-kappaB impairs reconsolidation of morphine reward memory in ratsBehav Brain Res2011216259259620816896
   PubMed Web of Science ®Google Scholar
• BackusKHBergerTKettenmannHActivation of neurokinin receptors modulates K+ and Cl− channel activity in cultured astrocytes from rat cortexBrain Res199154111031091709385
   PubMed Web of Science ®Google Scholar
• RimonRLe GrevesPNybergFHeikkilaLSalmelaLTereniusLElevation of substance P-like peptides in the CSF of psychiatric patientsBiol Psychiatry19841945095166203562
   PubMed Web of Science ®Google Scholar
• HargreavesRImaging substance P receptors (NK1) in the living human brain using positron emission tomographyJ Clin Psychiatry200263182412562139
   PubMed Web of Science ®Google Scholar
• HietalaJNymanMJEskolaOVisualization and quantification of neurokinin-1 (NK1) receptors in the human brainMol Imaging Biol20057426227216155744
   PubMed Web of Science ®Google Scholar
• WhittyCJPaulMABannonMJNeurokinin receptor mRNA localization in human midbrain dopamine neuronsJ Comp Neurol199738233944009183701
   PubMed Web of Science ®Google Scholar
• OkumuraMArakawaRItoHQuantitative analysis of NK1 receptor in the human brain using PET with 18F-FE-SPA-RQJ Nucl Med200849111749175518927336
   PubMed Web of Science ®Google Scholar
• SajiKIkedaYKimWAcute NK(1) receptor antagonist administration affects reward incentive anticipation processing in healthy volunteersInt J Neuropsychopharmacol20131671461147123406545
   PubMed Web of Science ®Google Scholar
• BlaineSClausEHarlaarNHutchisonKTACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependenceAlcohol Clin Exp Res201337Suppl 1E125E13023078527
   PubMed Web of Science ®Google Scholar
• SeneviratneCAit-DaoudNMaJZChenGJohnsonBALiMDSusceptibility locus in neurokinin-1 receptor gene associated with alcohol dependenceNeuropsychopharmacology200934112442244919553914
   PubMed Web of Science ®Google Scholar
• HeiligMGoldmanDBerrettiniWO’BrienCPPharmacogenetic approaches to the treatment of alcohol addictionNat Rev Neurosci2011121167068422011682
   PubMed Web of Science ®Google Scholar
• AntonRFOrosziGO’MalleySAn evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyArch Gen Psychiatry200865213514418250251
   PubMed Web of Science ®Google Scholar
• WalshSLHeiligMNuzzoPAHendersonPLofwallMREffects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusersAddict Biol201318233234322260216
   PubMed Web of Science ®Google Scholar
• GeorgeDTGilmanJHershJNeurokinin 1 receptor antagonism as a possible therapy for alcoholismScience200831958691536153918276852
   PubMed Web of Science ®Google Scholar
• KwakoLEGeorgeDTSchwandtMLThe neurokinin-1 receptor antagonist aprepitant in co-morbid alcohol dependence and posttraumatic stress disorder: a human experimental studyPsychopharmacology2015232129530425030801
   PubMed Web of Science ®Google Scholar
• RidlerKGunnRNSearleGECharacterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PETJ Psychopharmacol201428324425324429221
   PubMed Web of Science ®Google Scholar
• Largent-MilnesTMYamamotoTNairPSpinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced toleranceBr J Pharmacol20101615986100120977451
   PubMed Web of Science ®Google Scholar
• YamamotoTNairPJacobsenNEThe importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsJ Med Chem200851206334634718821747
   PubMed Web of Science ®Google Scholar
• SandweissAStarkJLargent-MilnesTMAn opioid agonist/NK1 antagonist inhibits nociception in an animal model of neuropathic pain while lacking accumbens dopamine releaseInternational Narcotics Research Conference2015Phoenix, AZ
   Google Scholar
• IngiTKitajimaYMinamitakeYNakanishiSCharacterization of ligand-binding properties and selectivities of three rat tachykinin receptors by transfection and functional expression of their cloned cDNAs in mammalian cellsJ Pharmacol Exp Ther199125939689751662278
   PubMed Web of Science ®Google Scholar